🚀 From Google Podcasts to Moon FM in No Time: Your Hassle-Free Migration Guide
👉

Talking Points

TCTMD

A selection of the best interviews conducted by p…

  • 8 minutes 5 seconds
    OCT vs IVUS vs Angiography: A Meta-analysis
    Gregg Stone and C. Michael Gibson discuss an updated meta-analysis addressing intravascular imaging in DES implantation.
    11 September 2024, 12:16 pm
  • 6 minutes 52 seconds
    The ATTRibute-CM Trial
    Julian Gillmore and C. Michael Gibson discuss the efficacy of acoramidis for patients with transthyretin amyloid cardiomyopathy.
    4 September 2024, 12:48 pm
  • 10 minutes 28 seconds
    The ADVENT Trial
    Vivek Reddy and C. Michael Gibson compare pulsed field ablation versus thermal ablation for patients with paroxysmal atrial fibrillation.
    14 August 2024, 4:00 am
  • 7 minutes 48 seconds
    The ARAMIS Trial
    Mathieu Kerneis and C. Michael Gibson compare outcomes of patients treated with anakinra, a new therapy for acute myocarditis, or placebo.
    7 August 2024, 3:29 pm
  • 9 minutes 50 seconds
    The NITRATE-CIN Trial
    Dan Jones and C. Michael Gibson discuss whether inorganic nitrate reduces contrast-induced nephropathy after angiography in ACS patients.
    31 July 2024, 1:12 pm
  • 9 minutes 33 seconds
    The DICTATE-AHF Trial
    Zachary Cox and C. Michael Gibson discuss whether early dapagliflozin initiation is safe and effective for patients with acute heart failure.
    10 July 2024, 1:05 pm
  • 8 minutes 14 seconds
    The RIGHT Trial
    Shaoping Nie, Gilles Montalescot, and C. Michael Gibson discuss prolonged anticoagulation after primary PCI for patients with MI.
    3 July 2024, 4:00 am
  • 5 minutes 51 seconds
    Four-Year Results: The EVOLUT Low Risk Trial
    Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR.
    12 June 2024, 1:09 pm
  • 10 minutes 29 seconds
    The AGENT IDE Trial
    Robert W. Yeh and C. Michael Gibson discuss the primary outcomes of this eagerly awaited trial comparing the AGENT paclitaxel-coated balloon with conventional balloon angioplasty for in-stent restenosis.
    5 June 2024, 9:00 am
  • 6 minutes 50 seconds
    The TRISCEND II Trial
    Susheel K. Kodali and C. Michael Gibson discuss transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation.
    22 May 2024, 1:05 pm
  • 5 minutes
    The VIVA Trial
    Josep Rodés-Cabau and C. Michael Gibson discuss the benefits of TAVI versus SAVR in patients with severe aortic stenosis and small aortic annuli.
    15 May 2024, 1:42 pm
  • More Episodes? Get the App
About Talking Points
Links
Listeners Also Subscribed To
© MoonFM 2024. All rights reserved.